These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37376975)

  • 21. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin.
    Marion MH; Humberstone M; Grunewald R; Wimalaratna S
    Pract Neurol; 2016 Aug; 16(4):288-95. PubMed ID: 26976927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cervical dystonia: effectiveness of a standardized physical therapy program; study design and protocol of a single blind randomized controlled trial.
    van den Dool J; Visser B; Koelman JH; Engelbert RH; Tijssen MA
    BMC Neurol; 2013 Jul; 13():85. PubMed ID: 23855591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
    Jinnah HA; Comella CL; Perlmutter J; Lungu C; Hallett M;
    Toxicon; 2018 Jun; 147():89-95. PubMed ID: 28888929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a single botulinum toxin treatment on somatosensory processing in idiopathic isolated cervical dystonia: an observational study.
    De Pauw J; Cras P; Truijen S; Mercelis R; Michiels S; Saeys W; Vereeck L; Hallemans A; De Hertogh W
    J Neurol; 2018 Nov; 265(11):2672-2683. PubMed ID: 30196326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia.
    Silbergleit AK; Isabell K; Turnbull J; Patel N; Boettcher E; Konnai R; Collins D; Sidiropoulos C; Schultz L
    Dysphagia; 2023 Oct; 38(5):1421-1429. PubMed ID: 37071189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The barriers and facilitators to satisfaction with botulinum neurotoxin treatment in people with cervical dystonia: a systematic review.
    Boyce MJ; McCambridge AB; Bradnam LV; Canning CG; Verhagen AP
    Neurol Sci; 2022 Aug; 43(8):4663-4670. PubMed ID: 35593979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emotional well-being and pain could be a greater determinant of quality of life compared to motor severity in cervical dystonia.
    Klingelhoefer L; Kaiser M; Sauerbier A; Untucht R; Wienecke M; Mammadova K; Falkenburger B; Gregor O; Chaudhuri KR; Reichmann H
    J Neural Transm (Vienna); 2021 Mar; 128(3):305-314. PubMed ID: 33146753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the initial severity on later outcome: retrospective analysis of a large cohort of botulinum toxin naïve patients with idiopathic cervical dystonia.
    Hefter H; Samadzazeh S; Rosenthal D
    J Neurol; 2021 Jan; 268(1):206-213. PubMed ID: 32761340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic cortical gray matter volume changes after botulinum toxin in cervical dystonia.
    Delnooz CC; Pasman JW; van de Warrenburg BP
    Neurobiol Dis; 2015 Jan; 73():327-33. PubMed ID: 25447226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
    Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond a motor disorder: a prospective evaluation of sleep quality in cervical dystonia.
    Eichenseer SR; Stebbins GT; Comella CL
    Parkinsonism Relat Disord; 2014 Apr; 20(4):405-8. PubMed ID: 24486141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of the Course of Disease before Botulinum Toxin Therapy on the Course of Treatment and Long-Term Outcome in Cervical Dystonia.
    Hefter H; Schomaecker I; Schomaecker M; Rosenthal D; Samadzadeh S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot Study.
    Hefter H; Schomaecker I; Schomaecker M; Ürer B; Brauns R; Rosenthal D; Albrecht P; Samadzadeh S
    Toxins (Basel); 2023 Jun; 15(7):. PubMed ID: 37505701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of non-motor symptoms and their association with quality of life in cervical dystonia.
    Han V; Skorvanek M; Smit M; Turcanova Koprusakova M; Hoekstra T; van Dijk JP; Tijssen MAJ; Gdovinova Z; Reijneveld SA
    Acta Neurol Scand; 2020 Dec; 142(6):613-622. PubMed ID: 32579704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
    Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ
    J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Headache attributed to craniocervical dystonia: A prospective cohort study.
    Eugenio Ramalho Bezerra M; Sampaio Rocha-Filho PA
    Eur J Pain; 2020 Sep; 24(8):1484-1494. PubMed ID: 32422691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.